Africa’s pharmaceutical industry has undergone tremendous growth in all sectors over the years. This growth can be attributed to improvements in infrastructure, health care capacity, and business environment.

The COVID-19 pandemic, however, brought to light the critical need for a more structured, robust, and resilient manufacturing sector for the continent. The industry was pushed by crisis to pick up the pace at establishing harmony within its different sectors, ensuring that they largely serve communities within Africa, and reduce over-reliance on pharmaceutical imports.

This crisis also prompted increased political support for local medical products manufacturing, leading to a substantial expansion of African pharmaceutical manufacturing.